Autonomous resupply of freeze-dried plasma and whole blood to a forward casualty position beyond ground reach
Hemorrhage remains the leading cause of preventable death on the battlefield. Survival depends on how quickly a bleeding casualty receives blood products — yet in dispersed, contested, or low-resource conflict zones, the nearest blood supply may be hours away by road, while air assets are tied up or too vulnerable to fly. Drone logistics emerged directly from this resupply gap.
Data from the U.S. Department of Defense Trauma Registry and allied combat casualty studies consistently show that hemorrhage — not head injury or infection — is the dominant cause of potentially survivable death in combat, accounting for roughly 80–90% of such deaths. Most casualties who die from bleeding do so within the first 30–60 minutes of injury, well before they reach a surgical facility.
The military "golden hour" policy, formalized after Iraq and Afghanistan, mandated that casualties reach a surgical team within 60 minutes of injury. That policy assumed reliable helicopter MEDEVAC. In a large-scale, dispersed, or contested fight — the kind planners now call "large-scale combat operations" — air superiority cannot be guaranteed, MEDEVAC helicopters are scarce and vulnerable, and casualties may be scattered across terrain with no clear ground line of communication. The golden hour becomes aspirational rather than achievable.
Joint Trauma System analyses of combat casualty data found that casualties who received blood products earlier — closer to the point of injury rather than only at a field hospital — had meaningfully better survival odds, reinforcing the push to move blood forward rather than waiting for the casualty to reach it.
Forward blood supply has always been logistically difficult: blood products are perishable, require temperature control, and cannot simply be pre-positioned everywhere in unlimited quantity. In a conventional, front-line war, ground and air MEDEVAC routes can be interdicted by enemy fire, GPS-denial, or terrain (mountains, urban rubble, flooded roads).
This creates a mismatch: the casualty needs blood within minutes to tens of minutes, but the nearest resuscitation node with blood products may be tens of kilometers away, reachable only by a route that takes hours under fire — if it is passable at all. Small unmanned aircraft systems (UAS) close this gap because they can fly point-to-point over terrain and threats that stop wheeled vehicles, at a fraction of the risk exposure of putting a MEDEVAC helicopter and crew over the same ground.
Small multirotor and fixed-wing UAS became attractive for casualty resupply because they combine several properties that ground vehicles and manned aircraft cannot: no onboard crew at risk, low radar/thermal signature relative to a helicopter, ability to fly nap-of-the-earth or low-altitude routes, and increasingly mature autonomy that removes the need for a pilot to be in radio contact throughout the flight — useful when jamming disrupts communications.
The tradeoff is payload: a small quadcopter typically carries only a few kilograms over ranges of roughly 10–30+ km, so what gets loaded matters enormously. This is exactly why the parallel development of lightweight, shelf-stable blood products — freeze-dried plasma foremost among them — has been just as important to the concept as the aircraft itself.
The concept of launching an aircraft loaded with blood from a rear logistics point is not speculative — it is already operating at national scale in civilian humanitarian logistics, and has been tested repeatedly by military services as a battlefield analog. Zipline's blood-delivery network is the most mature real-world precedent for exactly this drone launch step.
Zipline began operating fixed-wing delivery drones out of a central distribution hub in Muhanga, Rwanda in 2016, launching aircraft loaded with blood units that fly to rural clinics and parachute the package down near the requesting facility — no runway or landing required at the delivery end. The service was created to solve almost exactly the problem drone blood delivery for combat casualties targets: clinics far from the national blood bank could not reliably stock every blood type and product, leading to stockouts, wastage of unused units nearing expiry, and delayed transfusion for patients (often obstetric hemorrhage cases) who needed blood in minutes, not hours.
Rwanda's national blood transfusion service reported that after the drone network was integrated, rural facility blood requests could be filled in under 30 minutes on average — a delivery time previously only achievable for clinics near the capital. The model has since expanded to Ghana, Nigeria, Kenya, and to hospital systems in the United States, hauling blood, plasma, and other time-critical medical products.
Rwanda's health ministry and Zipline reported that on-demand drone resupply let rural clinics stop holding large local blood reserves at all — cutting reported blood product wastage from routine over-stocking dramatically, because units could be summoned only when actually needed rather than stored "just in case" until they expired.
Building on the civilian precedent, U.S. and allied militaries have run repeated field experiments using small quadcopter and fixed-wing UAS to move blood products, tourniquets, and other Tactical Combat Casualty Care (TCCC) supplies to simulated forward positions. Army, Air Force, and special operations units have tested platforms in the same weight class as commercial delivery drones (roughly 2–9 kg payload, tens of kilometers range) specifically to validate that whole blood and freeze-dried plasma survive the flight, vibration, and thermal exposure intact and functional on arrival.
These experiments consistently focus on the same operational questions the civilian programs already answered at scale: can the aircraft launch and navigate with minimal operator burden, does the payload arrive within temperature and integrity tolerances, and can delivery happen without exposing a manned aircraft or ground vehicle to the same route.
A launch is only useful if the payload is one the aircraft can actually carry and the field can actually use without a cold chain. This is why freeze-dried plasma (FDP) and Low Titer O Whole Blood (LTOWB) — covered in later stages — are so tightly linked to the drone resupply concept: FDP's room-temperature shelf stability and low weight per treatable dose make it disproportionately well suited to small UAS payload budgets compared to liquid plasma or refrigerated packed red cells, which need insulated, powered cold-chain packaging that eats into the aircraft's already limited weight allowance.
Flying a resupply drone across a live battlefield is not a straight line from A to B. Modern small-UAS logistics rely on autonomy software that ingests known and suspected threat locations — air defense systems, jamming corridors, likely small-arms engagement areas — and computes a route that trades a longer flight time for a materially lower probability of the payload being shot down or the link being jammed.
Autonomous delivery drones for casualty resupply are built around mission-planning software that treats terrain and threat data as a cost surface, not just a set of GPS waypoints. Known or suspected air-defense positions, radio/GPS jamming corridors, and areas with recent small-arms or MANPADS activity are weighted as "expensive" regions the planner tries to avoid, similar in principle to how a rideshare app avoids traffic — except the cost being minimized here is probability of payload loss, not minutes.
Because the tactical picture changes quickly, many programs push updated threat overlays to the aircraft before launch and, where the link allows, mid-flight, so a drone launched against an outdated threat picture can still divert around a newly identified danger area rather than flying a route planned hours earlier.
Contested airspace increasingly means contested navigation: adversaries jam or spoof GPS/GNSS signals specifically to defeat small UAS. Resilient platforms combine GNSS with inertial navigation (INS), visual-inertial odometry, and terrain-referenced navigation so the aircraft can hold a reasonably accurate course even when satellite positioning is degraded or denied outright — a capability that matters enormously for a mission where "close enough" to the casualty's coordinates is not good enough; the delivery point needs to be within a few meters of a medic on the ground.
Higher threat levels do not just add danger — they add delay. A route that must weave around several jamming corridors and suspected air-defense positions can add tens of percent to total flight distance, directly trading airspace risk for extra minutes before blood reaches the casualty — the same tension that makes contested-terrain ground resupply slow in the first place.
The single biggest limitation of drone blood delivery in a peer or near-peer fight is the proliferation of counter-UAS (C-UAS) systems: dedicated jammers, directed-energy weapons, interceptor drones, and even small arms fire directed at low, slow-flying logistics drones. A small quadcopter has essentially no defensive countermeasures and limited speed to outrun a determined threat, so mission planners lean heavily on altitude, terrain masking, and route diversity — flying different paths each time — rather than any onboard protection.
Payload-range tradeoffs compound the problem: greater standoff distance from threats, or longer detour routes, both cost battery endurance, and the aircraft still has to carry a useful blood-product mass. This is an active area of military experimentation, balancing aircraft size, speed, autonomy sophistication, and expendability (some units treat small logistics UAS as consumable, accepting a percentage loss rate as the cost of getting most deliveries through).
Arriving over the casualty is only half the mission — a contested or improvised landing zone often makes touchdown dangerous or impossible. Delivery drones instead hold a stable hover and lower the blood product package on a tether or release it by parachute, so the medic below can retrieve it within seconds without the aircraft ever settling on unstable, mined, or exposed ground.
Multirotor logistics drones typically favor a tethered winch delivery: the aircraft holds position in a stable hover directly above the marked casualty position and lowers the package on a cable at a controlled rate, allowing the medic to detach it by hand without the drone ever coming within reach of the ground or an occupant needing to touch the aircraft. This preserves precision — the package lands essentially exactly where the medic is standing — at the cost of hover time, during which the aircraft is a slow, low, and comparatively exposed target.
Fixed-wing platforms (the Zipline model) instead release the package by parachute while flying past at altitude, trading some drop-point accuracy (typically within a few meters of a marked target) for never having to slow down or loiter over the delivery point at all, which matters more in higher-threat settings.
A literal landing zone near an active casualty is often the worst place an aircraft — manned or unmanned — can be asked to touch down: unstable rubble, unknown mines or unexploded ordnance, incoming fire, or simply no flat clear ground exist at many points-of-injury. MEDEVAC helicopter doctrine has always had to contend with this, often requiring hoist extraction rather than landing for exactly the same reasons.
Small resupply drones sidestep the whole problem on the inbound leg: because the payload is small and the aircraft does not need to accommodate a stretcher or crew, it never has to land at all to deliver blood forward. It can hover briefly or simply overfly, and depart immediately after release — minimizing the time any aircraft spends exposed directly over the casualty.
Because the delivery point is precise, a single flight can service a casualty position located inside terrain no vehicle could reach — a rooftop, a streambed, a position behind a treeline under observation — provided the medic can transmit accurate coordinates for the drop.
Delivery is not complete until the medic confirms the product is intact and within acceptable temperature range — jostling, altitude-driven pressure changes, and ambient heat during a long contested-route flight can all affect fragile blood components. Packaging for drone-delivered blood typically includes passive insulation (phase-change cooling packs for products needing refrigeration) and, increasingly, small temperature loggers so the receiving medic — or a rear command node monitoring telemetry — can confirm the cold chain, where one is required, was not broken in flight.
Once the package reaches the medic, the mission's purpose is realized: blood or plasma goes into the casualty within minutes of arrival rather than hours after evacuation begins. This final stage rests on decades of combat-medicine evidence that earlier blood product administration saves lives, and on logistics-friendly products — freeze-dried plasma and low-titer whole blood — engineered specifically to make this moment possible without a hospital nearby.
Freeze-dried plasma (FDP) is plasma that has been lyophilized into a stable powder, then reconstituted with sterile water at the point of care in a few minutes before infusion. Unlike liquid fresh frozen plasma, which must be kept frozen and then thawed, FDP is stable at room temperature for roughly a year or more, is far lighter and more compact per treatable dose, and needs no freezer, generator, or cold chain at any point between production and use.
The French Armed Forces Blood Institute pioneered military use of lyophilized plasma decades ago, and the German armed forces have fielded their own product (LyoPlas) for years; both have used FDP operationally in expeditionary and combat settings. The U.S. military obtained expanded-access and later broader approval to use French and German freeze-dried plasma for its own forces in the 2010s, while domestic FDP products have since advanced toward U.S. licensure. FDP's room-temperature stability and light weight are precisely why it is the leading candidate payload for small UAS blood resupply — a drone with only a few kilograms of payload capacity can carry meaningfully more treatable plasma doses if it is not also hauling refrigeration.
French military lyophilized plasma has been used in combat casualty care since the Algerian War era and continuously refined since; NATO allies increasingly standardize on freeze-dried plasma specifically because it removes the cold-chain constraint that makes liquid blood products so hard to push to the point of injury.
When supply lines fail entirely and no manufactured product is available, military medicine falls back on the Low Titer O Whole Blood (LTOWB) "walking blood bank" concept: unit members are pre-screened and typed in advance so that, in an emergency, a low-titer group-O donor within the same unit can give whole blood directly for immediate transfusion to a casualty at or near the point of injury. This practice, refined during Ranger Regiment and special operations medicine in Iraq and Afghanistan, guarantees a transfusion source exists even when no cold-chain product has arrived — but it costs the unit a healthy soldier's blood and time, and depends on having pre-typed donors physically present.
Drone-delivered blood products are best understood as a way to reduce reliance on the walking blood bank rather than replace it outright: when a resupply drone can bring FDP or packaged LTOWB forward from a rear collection point, the unit does not have to bleed one of its own soldiers to treat another, preserving unit strength while still closing the transfusion gap quickly.
A growing body of evidence links earlier blood product administration in hemorrhagic shock to better outcomes, though the picture is nuanced. Retrospective combat casualty registry studies (drawing on the U.S. Department of Defense Trauma Registry and Joint Trauma System data) have repeatedly associated earlier prehospital blood or plasma transfusion with improved survival in casualties with significant hemorrhage, reinforcing "as far forward as possible" resuscitation doctrine.
Prospective randomized evidence is more mixed: the UK RePHILL trial (published in The Lancet Haematology, 2022) randomized trauma patients with hemorrhagic shock to prehospital packed red cells plus lyophilized plasma versus 0.9% saline, and found no statistically significant difference in the primary composite outcome, prompting debate over which patient subgroups and injury patterns benefit most from prehospital transfusion versus rapid transport to definitive care. The practical takeaway most combat-casualty-care programs draw is that early blood product administration is beneficial for casualties with ongoing major hemorrhage and delayed evacuation timelines specifically — exactly the scenario drone resupply targets — rather than a universal replacement for rapid surgical care.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Low Titer O Whole Blood (LTOWB) | Point-of-injury, walking blood bank | Fresh collection from pre-screened donor; contains all components (RBC, plasma, platelets) | Most physiologic replacement; ~24–35 day shelf life refrigerated, needs cold chain or fresh draw |
| Freeze-Dried Plasma (FDP) | Drone/air resupply, remote & austere care | Lyophilized plasma powder, reconstituted with water in minutes at point of care | Room-temperature stable ~1–2 yrs; lightest weight per dose; no cold chain — ideal drone payload |
| Packed Red Blood Cells (PRBC) | Role 2/3 facilities, forward resuscitation nodes | Centrifuged, concentrated red cells stored refrigerated (~1–6°C) | High oxygen-carrying capacity; ~42 day shelf life refrigerated; requires insulated cold-chain packaging |
| Liquid (Fresh Frozen) Plasma | Fixed medical facilities with freezers | Frozen plasma, thawed before use, richest in clotting factors | Full factor activity; but needs freezer storage and thaw time — least drone-deployable option |